Virulence of Mycobacterium intracellulare clinical strains in a mouse model of lung infection - role of neutrophilic inflammation in disease severity

被引:4
作者
Tateishi, Yoshitaka [1 ]
Ozeki, Yuriko [1 ]
Nishiyama, Akihito [1 ]
Miki, Mari [2 ]
Maekura, Ryoji [3 ]
Kida, Hiroshi [3 ]
Matsumoto, Sohkichi [1 ,4 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Dept Bacteriol, 1-757, Asahimachi-Dori, Chuo-Ku, Niigata 9518510, Japan
[2] Tokushima Prefecture Naruto Hosp, Naruto, Tokushima, Japan
[3] Natl Hosp Org, Osaka Toneyama Med Ctr, Dept Resp Med, Toyonaka, Japan
[4] Univ Airlangga, Inst Trop Dis, Lab TB, Surabaya, East Java, Indonesia
关键词
Nontuberculous mycobacteria; Mycobacterium intracellulare; Virulence; Neutrophil; Chemotherapeutic efficacy; REGULATORY T-CELLS; ANTITUBERCULOSIS TREATMENT; EPIDEMIOLOGIC ANALYSES; PARADOXICAL RESPONSE; AVIUM; SUSCEPTIBILITY; MICE; AUTOANTIBODIES; TUBERCULOSIS; PATHOGENESIS;
D O I
10.1186/s12866-023-02831-y
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
BackgroundMycobacterium intracellulare is a major etiological agent of Mycobacterium avium-intracellulare pulmonary disease (MAC-PD). However, the characteristics of the virulence of M. intracellulare and the in vivo chemotherapeutic efficacy remain unclear. In this study, we examined the virulence of nine M. intracellulare strains with different clinical phenotypes and genotypes in C57BL/6 mice.ResultsWe classified three types of virulence phenotypes (high, intermediate, and low) based on the kinetics of the bacterial load, histological lung inflammation, and neutrophilic infiltration. High virulence strains showed more severe neutrophilic infiltration in the lungs than intermediate and low virulence strains, with 6.27-fold and 11.0-fold differences of the average percentage of neutrophils in bronchoalveolar lavage fluid, respectively. In particular, the high virulence strain M.i.198 showed the highest mortality in mice, which corresponded to the rapid progression of clinical disease. In mice infected with the drug-sensitive high virulence strain M019, clarithromycin-containing chemotherapy showed the highest efficacy. Monotherapy with rifampicin exacerbated lung inflammation with increased lymphocytic and neutrophilic infiltration into the lungs.ConclusionsThe virulence phenotypes of clinical strains of M. intracellulare were diverse, with high virulence strains being associated with neutrophilic infiltration and disease progression in infected mice. These high virulence strains were proposed as a useful subject for in vivo chemotherapeutic experiments.
引用
收藏
页数:15
相关论文
共 52 条
  • [1] Prevalence of Nontuberculous Mycobacterial Lung Disease in US Medicare Beneficiaries
    Adjemian, Jennifer
    Olivier, Kenneth N.
    Seitz, Amy E.
    Holland, Steven M.
    Prevots, D. Rebecca
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (08) : 881 - 886
  • [2] Characterization of Mouse Models of Mycobacterium avium Complex Infection and Evaluation of Drug Combinations
    Andrejak, Claire
    Almeida, Deepak V.
    Tyagi, Sandeep
    Converse, Paul J.
    Ammerman, Nicole C.
    Grosset, Jacques H.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 2129 - 2135
  • [3] The efficacy of clarithromycin and the bicyclolide EDP-420 against Mycobacterium avium in a mouse model of pulmonary infection
    Bermudez, Luiz E.
    Motamedi, Nima
    Kolonoski, Peter
    Chee, Chris
    Baimukanova, Gail
    Bildfell, Robert
    Wang, Guoqiang
    Phan, Ly Tam
    Young, Lowell S.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (11) : 1506 - 1510
  • [4] Clinical and Immunologic Predictors of Mycobacterium avium Complex Immune Reconstitution Inflammatory Syndrome in a Contemporary Cohort of Patients With Human Immunodeficiency Virus
    Breglio, Kimberly F.
    Vinhaes, Caian L.
    Arriaga, Maria B.
    Nason, Martha
    Roby, Gregg
    Adelsberger, Joseph
    Andrade, Bruno B.
    Sheikh, Virginia
    Sereti, Irini
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (12) : 2124 - 2135
  • [5] KILLING OF VIRULENT MYCOBACTERIUM-TUBERCULOSIS BY REACTIVE NITROGEN INTERMEDIATES PRODUCED BY ACTIVATED MURINE MACROPHAGES
    CHAN, J
    XING, Y
    MAGLIOZZO, RS
    BLOOM, BR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) : 1111 - 1122
  • [6] Cheng SL, 2007, INT J TUBERC LUNG D, V11, P1290
  • [7] Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
    Daley, Charles L.
    Iaccarino, Jonathan M.
    Lange, Christoph
    Cambau, Emmanuelle
    Wallace Jr, Richard J.
    Andrejak, Claire
    Boettger, Erik C.
    Brozek, Jan
    Griffith, David E.
    Guglielmetti, Lorenzo
    Huitt, Gwen A.
    Knight, Shandra L.
    Leitman, Philip
    Marras, Theodore K.
    Olivier, Kenneth N.
    Santin, Miguel
    Stout, Jason E.
    Tortoli, Enrico
    van Ingen, Jakko
    Wagner, Dirk
    Winthrop, Kevin L.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (01)
  • [8] DNA hypermethylation during tuberculosis dampens host immune responsiveness
    Dinardo, Andrew R.
    Rajapakshe, Kimal
    Nishiguchi, Tomoki
    Grimm, Sandra L.
    Mtetwa, Godwin
    Dlamini, Qiniso
    Kahari, Jaquiline
    Mahapatra, Sanjana
    Kay, Alexander
    Maphalala, Gugu
    Mace, Emily M.
    Makedonas, George
    Cirillo, Jeffrey D.
    Netea, Mihai G.
    Van Crevel, Reinout
    Coarfa, Cristian
    Mandalakas, Anna M.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (06) : 3113 - 3123
  • [9] Doeing Diana C, 2003, BMC Clin Pathol, V3, P3
  • [10] Clinical features of dominant and recessive interferon γ receptor 1 deficiencies
    Dorman, SE
    Picard, C
    Lammas, D
    Heyne, K
    van Dissel, JT
    Baretto, R
    Rosenzweig, SD
    Newport, M
    Levin, M
    Roesler, J
    Kumararatne, D
    Casanova, JL
    Holland, SM
    [J]. LANCET, 2004, 364 (9451) : 2113 - 2121